English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Friday, August 15, 2025
业聚医疗2025年中期业绩收入及纯利双双增长 分别达8,360万美元及1,980万美元
18:10 HKT/SGT
廣發証券榮膺國家數據管理能力成熟度(DCMM)最高等級認証
17:28 HKT/SGT
米国株式アクティブ残高10年連続世界No.1ティー・ロウ・プライス[1] 日本法人が既存追加型株式投資信託に「毎月決算・予想分配金提示型」ファンドを新規設定
17:15 HKT/SGT
广发证券荣膺国家数据管理能力成熟度(DCMM)最高等级认证
17:12 HKT/SGT
TANAKA Holds Press Conference to Commemorate Its 140th Anniversary
02:00 HKT/SGT
Thursday, August 14, 2025
WL Delicious Announced 2025 Interim Results
23:05 HKT/SGT
RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements
23:00 HKT/SGT
RAK ICC以2025年立法升級加強基金會制度
23:00 HKT/SGT
RAK ICC以2025年立法升级加强基金会制度
23:00 HKT/SGT
卫龙美味公佈2025年中期業績
22:48 HKT/SGT
卫龙美味公布2025年中期业绩
22:30 HKT/SGT
The 35th Food Expo opens today
21:05 HKT/SGT
Re-opening of Food Expo and concurrent fairs
20:05 HKT/SGT
Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million
19:15 HKT/SGT
越秀房产基金整体经营稳定 实现收入逾人民币9.66亿元
18:42 HKT/SGT
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
18:00 HKT/SGT
越秀房產基金整體經營穩定 實現收入逾人民幣9.66億元
17:43 HKT/SGT
雲頂新耀維長寧(艾曲莫德)在中國台灣新藥上市申請獲受理 亞洲市場准入再迎里程碑
17:12 HKT/SGT
云顶新耀维长宁(艾曲莫德)在中国台湾新药上市申请获受理 亚洲市场准入再迎里程碑
17:12 HKT/SGT
Mitsubishi Corporation to acquire shares in Copper World copper mine project in the US
11:05 HKT/SGT
FWD Group marks 12th anniversary with 12 community grants
11:00 HKT/SGT
アリックスパートナーズ、「2025 年アジア版ターンアラウンド & リストラクチャリング調査」を発表
11:00 HKT/SGT
TANAKA PRECIOUS METAL GROUP宣布與JEPLAN進行事業合作,以邁向實現脫碳和循環型社會
11:00 HKT/SGT
TANAKA PRECIOUS METAL GROUP宣布将与JEPLAN进行业务合作以实现脱碳与循环型社会
11:00 HKT/SGT
富衛集團慶祝成立12週年 推出12項社區關愛撥款計劃
10:19 HKT/SGT
TANAKA PRECIOUS METAL GROUP, 탄소중립 및 순환형 사회실현을 위해 (주)JEPLAN과 사업 제휴 발표
10:00 HKT/SGT
Rainstorm special arrangements of Food Expo and concurrent fairs
09:41 HKT/SGT
Focus Graphite Advances ESIA Reporting at Lac Knife and Accelerates Mineral Resource Expansion at Lac Tetepisca and Announces the Grant of Options and RSUs
06:59 HKT/SGT
Wednesday, August 13, 2025
NMPA已受理亿胜生物关于EB12-20145P(HLX04-O)用于治疗湿性年龄相关性黄斑变性的生物制品许可申请
21:25 HKT/SGT
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
20:24 HKT/SGT
NMPA已受理億勝生物關於EB12-20145P(HLX04-O)用於治療濕性年齡相關性黃斑變性的生物製品許可申請
20:24 HKT/SGT
潼關黃金獲納入MSCI全球小型股指數 資本市場影響力進一步提升
19:19 HKT/SGT
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
14:00 HKT/SGT
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
12:00 HKT/SGT
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
11:27 HKT/SGT
AI Inference vs. AI Training: What Are the Differences?
11:00 HKT/SGT
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
10:15 HKT/SGT
首程控股(0697.HK)抽取88位幸運觀眾現場觀賽 深度參與世界人形機器人運動會
09:58 HKT/SGT
首程控股(0697.HK)抽取88位幸运观众现场观赛 深度参与世界人形机器人运动会
09:43 HKT/SGT
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景
09:27 HKT/SGT
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景
09:27 HKT/SGT
T-RIZE Group Lists $RIZE Token on Revolut App, Expanding Global Access to Tokenized Real-World Assets
07:30 HKT/SGT
Formerra 成為 Syensqo PVDF 的北美區經銷商
07:00 HKT/SGT
Tuesday, August 12, 2025
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
21:18 HKT/SGT
五礦資源公佈2025年中期業績 強勁銅產量驅動利潤、收益和現金流增長
21:07 HKT/SGT
 ACN Search:
 
Abdullah Ayed Al Mazny, General Manager at Desert Dragon (ICS Arabia), and Ghufran Hamid, CEO of XDS, at the '10Mw Immersive Cooling for Ai Worlkload' Signing Ceremony on July 8, 2025.
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575